Monash IVF Group (MVF) Stock Price, News & Analysis

Company Overview

Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is based in Cremorne, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 9.00 million shs
• Average Volume: N/A
• Market Capitalization: $455.87 million
• P/E Ratio: N/A
• Dividend Yield: 4.27%
• Price Target: N/A
• Consensus Rating: N/A

MVF Stock Analysis - Frequently Asked Questions

How were Monash IVF Group's earnings last quarter?

Monash IVF Group Limited (ASX:MVF) posted its quarterly earnings data on Monday, August, 27th. The company reported $0.09 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.10 by $0.01. Monash IVF Group had a negative trailing twelve-month return on equity of 2.52% and a negative net margin of 2.56%.

What other stocks do shareholders of Monash IVF Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Monash IVF Group investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Surgery Partners (SGRY), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX) and Aldeyra Therapeutics (ALDX).

Company Calendar

• Last Earnings: 8/27/2018
• Ex-Dividend for 4/10 Dividend: 3/05/2025
• Record date for 4/10 Dividend: 4/10/2025
• Dividend Payable: 4/10/2025
• Today: 5/14/2025

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Diagnostics & Research
• Sub-Industry: Financial Services
• Current Symbol: ASX:MVF
• CIK: N/A
• Web: www.monashivfgroup.com.au
• Phone: +61-3-94208235
• Fax: N/A
• Employees: 997
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): A($0.02)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: 8.25
• Net Income: $-6,530,000.00
• Net Margins: -2.56%
• Pretax Margin: N/A
• Return on Equity: -2.52%
• Return on Assets: -0.62%

Debt

• Debt-to-Equity Ratio: 55.96
• Current Ratio: 0.47
• Quick Ratio: 0.43

Sales & Book Value

• Annual Sales: $255.22 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 27.14
• Book Value: A$0.64 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 389,640,000
• Free Float: N/A
• Market Cap: $455.87 million
• Optionable: Not Optionable
• Beta: 1.40